Join to View Full Profile
9000 Rockville PikeBldg 10 Crc Room 2-5950Bethesda, MD 20892
Phone+1 301-496-6353
Fax+1 301-402-0922
Are you Dr. Srinivasan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ramaprasad Srinivasan, MD is a general surgeon in Bethesda, Maryland. He is currently licensed to practice medicine in Virginia.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 1999
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1996 - 1997
Bangalore Medical CollegeClass of 1991
Certifications & Licensure
VA State Medical License 2000 - 2026
Publications & Presentations
PubMed
- Corrigendum.Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen
Ophthalmology. 2025-03-01 - Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogen...Phuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, Emily McDuffee, Tatyana Worthy
Bone Marrow Transplantation. 2024-12-01 - 2 citationsOral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.Henry E Wiley, Ramaprasad Srinivasan, Jodi K Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen
Ophthalmology. 2024-11-01
Press Mentions
Belzutifan Active in Von Hippel-Lindau Disease-Associated Renal Cell CarcinomaNovember 24th, 2021- No Benefit with Adjuvant Sorafenib in intermediate-/high-risk RCCNovember 2nd, 2020
Grant Support
- Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCCDIVISION OF BASIC SCIENCES - NCIPresent
- Novel Approaches to Targeting Cancers Associated with VHL MutationsDIVISION OF BASIC SCIENCES - NCIPresent
- Novel Approaches to Targeting Cancers Associated with VHL MutationsDIVISION OF BASIC SCIENCES - NCIPresent
- Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCCDIVISION OF BASIC SCIENCES - NCIPresent
